References
- Kussmaul A. Die Störungen der Sprache. Leipzig: FCW Vogel; 1877.
- Tramer M. Elective mutism. Z Kinderpsychiatr 1934;1:30–5.
- Brown JB, Lloyd H. A controlled study of children not speak-ing at school. J Assoc Workers Maladjust Child 1975;3:49–63.
- Fundudis T, Kolvin I, Garside R. Speech retarded and deaf children: their psychological development. London: Academic Press; 1979.
- World Health Organization. ICD-10 international classification of mental disorders. Geneva: World Health Organization; 1992.
- Hayden TL. Classification of elective mutism. J Am Acad Child Psychiatry 1980;19:118–33.
- Kolvin I, Fundudis T. Elective mute children: psychological development and background factors. J Child Psychol Psychi-atry 1981;22:219–32.
- Andersson CB, Thomsen PH. Elective mutism. An analysis of 37 Danish cases. Nord J Psychiatry 1998;52: 231–8.
- Browne E, Wilson V, Layborn PC. Diagnosis and treatment of elective mutism in children. J Am Acad Child Psychiatry 1963;2:605–17.
- Steinhausen HC, Juzi C. Elective mutism: an analysis of 100 cases. J Am Acad Child Adolesc Psychiatry 1996;35:606–21.
- Labbe EE, Wiliamson DA. Behavioural treatment of elective mutism: a review of the literature. Clin Psychol Rev 1984;4:273–94.
- Black B, Uhde TW. Elective mutism as a variant of social phobia. J Am Acad Child Adolesc Psychiatry 1992;31:1090–4.
- Black B, Uhde TW. Fluoxetine treatment of elective mutism; a double blind placebo-controlled study. J Am Acad Child Ado-lesc Psychiatry 1994;33:1000–6.
- Dummit ES 3rd, Klein RG, Tancer NK, Asche B, Martin J. Fluoxetine treatment of children with selective mutism: an open trial. J Am Acad Child Adolesc Psychiatry 1996;35: 615–21.
- Montgomery SA, Rasmussen JGC, Tanghoj P. A 24 week study of 20 mg citalopram, 40 mg citalopram and placebo in the prevention of relapse of major depression. Int Clin Psy-chopharmacol 1993;8: 181–8.
- Thomsen PH. Child and adolescent obsessive-compulsive disor-der treated with citalopram: findings from an open trial of 23 cases. J Child Adolesc Psychopharmacol 1997;7:157–66.
- Riddle MA, Hardin MT, King R, Scohill L, Woolston JL. Fluoxetine treatment of children and adolescents with Tourette's syndrome and obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1990;29:45–8.
- Apter A, Ratzoni G, King R. Fluvoxamine open-label treat-ment of adolescent in-patients with OCD or depression. J Am Acad Child Adolesc Psychiatry 1994;33:342–8.
- March JA, Biederman J, Wolkow R, Safferman A, Mardelian J, Cook EH, et al. Sertraline in children and adolescents with obsessive-compulsive disorder. A multicenter randomized con-trolled trial. JAMA 1998;20:1752–6.